Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shedlock

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Plos Neglected Tropical Diseases|May 4, 2010
Chikungunya: a potentially emerging epidemic?Michelle M Thiboutot, Senthil Kannan, Omkar U Kawalekar, et al.
Current HIV Research|March 12, 2009
HIV-1 Vpr: regulator of viral survivalKhanh P Thieu, Matthew P Morrow, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in miceDevon J Shedlock, Kendra T Talbott, Stephan J Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaquesMatthew P Morrow, Jian Yan, Panyupa Pankhong, et al.
Human Vaccines|November 24, 2011
Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liverKrystle A Lang Kuhs, Roberta Toporovski, Arielle A Ginsberg, et al.
Gene Therapy|May 6, 2011
Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationP Fagone, D J Shedlock, H Bao, et al.
Vaccines|September 8, 2015
Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced ImmunityDevon J Shedlock, Colleen Tingey, Lavanya Mahadevan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and EbolaDevon J Shedlock, Jenna Aviles, Kendra T Talbott, et al.
Immunology|September 11, 2009
Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cellsGowtham Muthumani, Dominick J Laddy, Senthil G Sundaram, et al.
Molecular Therapy. Nucleic Acids|August 22, 2022
Erratum: Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of T<sub>SCM</sub>-enriched allogeneic CAR-T cellsBlair B Madison, Deepak Patil, Maximilian Richter, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Plos Neglected Tropical Diseases|May 4, 2010
Chikungunya: a potentially emerging epidemic?Michelle M Thiboutot, Senthil Kannan, Omkar U Kawalekar, et al.
Current HIV Research|March 12, 2009
HIV-1 Vpr: regulator of viral survivalKhanh P Thieu, Matthew P Morrow, Devon J Shedlock, et al.
Human Vaccines & Immunotherapeutics|November 16, 2012
Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in miceDevon J Shedlock, Kendra T Talbott, Stephan J Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2010
IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaquesMatthew P Morrow, Jian Yan, Panyupa Pankhong, et al.
Human Vaccines|November 24, 2011
Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liverKrystle A Lang Kuhs, Roberta Toporovski, Arielle A Ginsberg, et al.
Gene Therapy|May 6, 2011
Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccinationP Fagone, D J Shedlock, H Bao, et al.
Vaccines|September 8, 2015
Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced ImmunityDevon J Shedlock, Colleen Tingey, Lavanya Mahadevan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and EbolaDevon J Shedlock, Jenna Aviles, Kendra T Talbott, et al.
Immunology|September 11, 2009
Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cellsGowtham Muthumani, Dominick J Laddy, Senthil G Sundaram, et al.
Molecular Therapy. Nucleic Acids|August 22, 2022
Erratum: Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of T<sub>SCM</sub>-enriched allogeneic CAR-T cellsBlair B Madison, Deepak Patil, Maximilian Richter, et al.
Pageof 7